Robert D Fagerlund (Robert Fagerlund)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Molecular Dynamics Simulations

Top Venues

Nature communications

Research square

The Biochemical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature 631 (8021) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature 631 (8021) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature (2024)
Evan A Schwartz, Jack P K Bravo, Mohd Ahsan, Luis A Macias, Caitlyn L McCafferty, Tyler L Dangerfield, Jada N Walker, Jennifer S Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund, David W Taylor
RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature communications 15 (1) (2024)
Nils Birkholz, Kotaro Kamata, Maximilian Feussner, Max E Wilkinson, Christian Cuba Samaniego, Angela Migur, Dari Kimanius, Marijn Ceelen, Sam C Went, Ben Usher, Tim R Blower, Warren P Tate, Chase L Beisel, Zasha Weinberg, Robert D Fagerlund, Simon A Jackson, Peter C Fineran
Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix protein. Nature 631 (8021) (2024)
David W Taylor, Evan Schwartz, Jack Bravo, Mohd Ahsan, Luis Macias, Caitlyn McCafferty, Tyler Dangerfield, Jada N Walker, Jennifer Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund
Type III CRISPR-Cas effectors act as protein-assisted ribozymes during RNA cleavage. Research square (2023)
Tess M McBride, Shaharn C Cameron, Peter C Fineran, Robert D Fagerlund
The biology and type I/III hybrid nature of type I-D CRISPR-Cas systems. The Biochemical journal 480 (7) (2023)
David W Taylor, Evan Schwartz, Jack Bravo, Mohd Ahsan, Luis Macias, Caitlyn McCafferty, Tyler Dangerfield, Jada N Walker, Jennifer Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund
Type III CRISPR-Cas effectors act as protein-assisted ribozymes during RNA cleavage. Research square (2023)
David W Taylor, Evan Schwartz, Jack Bravo, Mohd Ahsan, Luis Macias, Caitlyn McCafferty, Tyler Dangerfield, Jada N Walker, Jennifer Brodbelt, Giulia Palermo, Peter C Fineran, Robert D Fagerlund
Type III CRISPR-Cas effectors act as protein-assisted ribozymes during RNA cleavage. Research square (2023)
Sarah Camara-Wilpert, David Mayo-Muñoz, Jakob Russel, Robert D Fagerlund, Jonas Stenløkke Madsen, Peter C Fineran, Søren Johannes Sørensen, Rafael Pinilla-Redondo
Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs. Nature (2023)
Evan A Schwartz, Tess M McBride, Jack P K Bravo, Daniel Wrapp, Peter C Fineran, Robert D Fagerlund, David W Taylor
Structural rearrangements allow nucleic acid discrimination by type I-D Cascade. Nature communications 13 (1) (2022)
Nils Birkholz, Simon A Jackson, Robert D Fagerlund, Peter C Fineran
A mobile restriction-modification system provides phage defence and resolves an epigenetic conflict with an antagonistic endonuclease. Nucleic acids research 50 (6) (2022)
Simon A Jackson, Rebecca E McKenzie, Robert D Fagerlund, Sebastian N Kieper, Peter C Fineran, Stan J J Brouns
CRISPR-Cas: Adapting to change. Science (New York, N.Y.) 356 (6333) (2017)